作者：
Laura,Caleca [1]
;
Irene,Catucci [2]
;
Gisella,Figlioli [2]
;
Loris,De Cecco [3]
;
Tina,Pesaran [4]
;
Maggie,Ward [5]
;
Sara,Volorio [6]
;
Anna,Falanga [7]
;
Marina,Marchetti [8]
;
Maria,Iascone [7]
;
Carlo,Tondini [9]
;
Alberto,Zambelli [10]
;
Jacopo,Azzollini [10]
;
Siranoush,Manoukian [11]
;
Paolo,Radice [11]
;
Paolo,Peterlongo [1]
作者单位：
Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[1]
Genome Diagnostics Program, IFOM the FIRC Institute of Molecular Oncology, Milan, Italy.
[2]
Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[3]
Ambry Genetics, Department of Clinical Diagnostics, Aliso Viejo, CA, United States.
[4]
Cancer Outreach and Risk Assessment, Via Christi Hospitals, Wichita, KS, United States.
[5]
IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
[6]
Cogentech Cancer Genetics Test Laboratory, Milan, Italy.
[7]
Department of Immunohematology and Transfusion Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
[8]
USSD Laboratorio Genetica Medica, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
[9]
Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
[10]
Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[11]
DOI
10.3389/fonc.2018.00480
PMID
30410870
发布时间
2020-09-30
换一批
换一批
